Ionis Pharmaceuticals Inc (IONS) — Capital Reinvestment Ratio
Ionis Pharmaceuticals Inc (IONS) has a Capital Reinvestment Ratio of 0.03x as of June 2026, meaning it reinvests 0% of its operating cash flow ($565.53 Million) in capital expenditures ($16.08 Million). Check Ionis Pharmaceuticals Inc tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Ionis Pharmaceuticals Inc Capital Reinvestment Ratio (2007–2021)
This chart tracks Ionis Pharmaceuticals Inc's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Ionis Pharmaceuticals Inc.
Annual Capital Reinvestment Ratio for Ionis Pharmaceuticals Inc (2007–2021)
Year-by-year Capital Reinvestment Ratio for Ionis Pharmaceuticals Inc from 2007 to 2021. See IONS free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.58x | $30.80 Million | $17.90 Million | ▼ -49.2% |
| 2020 | 1.14x | $35.89 Million | $41.05 Million | ▲ +989.8% |
| 2019 | 0.10x | $345.72 Million | $36.28 Million | ▲ +258.4% |
| 2018 | 0.03x | $602.89 Million | $17.65 Million | ▼ -86.5% |
| 2017 | 0.22x | $174.15 Million | $37.86 Million | ▼ -60.9% |
| 2015 | 0.56x | $21.12 Million | $11.75 Million | ▼ -68.5% |
| 2014 | 1.77x | $6.29 Million | $11.10 Million | ▲ +1992.1% |
| 2013 | 0.08x | $63.49 Million | $5.36 Million | ▼ -96.9% |
| 2012 | 2.76x | $1.88 Million | $5.17 Million | ▲ +3323.7% |
| 2008 | 0.08x | $212.03 Million | $17.07 Million | ▼ -42.0% |
| 2007 | 0.14x | $36.09 Million | $5.01 Million | — |